Skip to content

Investigation of the incidence of FK506-induced pain after immunosuppressive therapy in liver transplantation patients

Investigation of the incidence of FK506-induced pain after immunosuppressive therapy in liver transplantation patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038315
Enrollment
Unknown
Registered
2020-09-17
Start date
2019-09-15
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic pain

Interventions

Liver transplant patient:Nil

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The inclusion criteria of case group were as follows 1. Patients with liver transplantation; 2. Patients older than 18 years old.

Exclusion criteria

Exclusion criteria: 1. Patients with liver cancer; 2. Patients with acute liver failure; 3. Patients with multiple liver transplantation or combined multiple organ transplantation; 4. Patients with inflammatory pain of any origin; 5. Patients with neuropathic pain of any origin; 6. Patients with chronic postoperative pain; 7. Patients with chronic secondary abdominal pain; 8. Patients with chronic cancer pain. All patients were informed of the relevant content before the investigation, signed the informed consent, and were informed that they had the right to withdraw during the investigation.

Design outcomes

Primary

MeasureTime frame
incidence of pain;

Secondary

MeasureTime frame
VAS PAIN SCORE;

Countries

China

Contacts

Public ContactPeifu Tang

Chinese PLA General Hospital

pftang301@163.com+86 13801379901

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026